Skip to main content

Companies

Latest Companies stories from Business & Industry.

Business & Industry

Tesla Reports Increased EV Sales Amidst Negative Cash Flows

Tesla has announced a rise in electric vehicle sales, yet the company is grappling with negative cash flows, raising questions about its financial health.

Business & Industry

Fermi Faces Uncertainty After CEO Departure

The unexpected exit of Fermi's CEO raises questions about the company's future and has left investors feeling uneasy about its direction.

Business & Industry

Polestar Faces Growing Net Losses in 2025 Amid Rising Revenue

Polestar's latest financial results indicate a troubling trend, with net losses widening even as revenue increases, raising questions about the sustainability of its growth.

Business & Industry

QXO's $17 Billion Acquisition of TopBuild Aims to Dominate US Building Products Market

Billionaire investor Brad Jacobs is pursuing a significant acquisition of TopBuild by QXO, potentially reshaping the US building products landscape.

Business & Industry

TotalEnergies Projects Strong Q1 Earnings Due to US-Iran Conflict

TotalEnergies is forecasting strong earnings for the first quarter, a projection that appears to be influenced by the ongoing conflict between the US and Iran.

Business & Industry

Evaluating Sigma Lithium's Valuation Amid New Financing and Production Projections

An overview of Sigma Lithium's recent financing achievements and production forecasts, highlighting its growth potential.

Business & Industry

Understanding the Kemp-Kasten Amendment and Its Impact on UNFPA Funding

This overview discusses the Kemp-Kasten amendment, which restricts U.S. funding to organizations like UNFPA based on their involvement with coercive abortion or involuntary sterilization.

Business & Industry

AngioDynamics, Inc. Reports Q3 2026 Financial Performance

An overview of AngioDynamics, Inc.'s financial results for the third quarter of 2026, highlighting key performance metrics.

Business & Industry

Gilead Acquires Tubulis for Over $3 Billion to Boost Oncology Portfolio

In a significant move to enhance its oncology pipeline, Gilead has announced the acquisition of Tubulis, a German biotech firm, for more than $3 billion.

Business & Industry

OceanFirst-Flushing merger deal gains shareholder nod

Strategic angle: Shareholders approve the merger between OceanFirst and Flushing.

Business & Industry

Dodge CEO: Affordable Sports Cars Still Have A Future

Strategic angle: Dodge CEO Matt McAlear said a sub-$30,000 performance car would make a lot of sense.

Business & Industry

Roundtable CEO James Heckman Details NASDAQ Strategy, Long-Term Focus, Capitalization Structure, and Lock-Up

Strategic angle: Insights from Roundtable CEO on strategic direction and financial structure.

Business & Industry

ASML Revenue Is About to Explode Higher Again

Strategic angle: ASML's financial outlook suggests significant revenue growth on the horizon.

Business & Industry

Goldman Sachs' blunt warning to laid-off tech workers: It will take time and earnings loss to find a new job

Strategic angle: Goldman Sachs cautions tech workers facing layoffs about the challenges of job searching and potential earnings loss.

Business & Industry

Briefing: PDD Holdings (PDD) Reports 2025 Revenue of RMB431.8B; Net Income Falls 12%

Strategic angle: PDD Holdings announces its financial results for 2025, revealing a significant revenue figure but a decline in net income.

Business & Industry

Briefing: Jim Cramer Praises Intel’s (INTC) CEO Lip-Bu Tan Once Again

Strategic angle: Jim Cramer highlights the leadership of Intel's CEO in a recent commentary.

Business & Industry

Briefing: Jim Cramer Discusses Starbucks (SBUX) CEO’s Turnaround Algorithm

Strategic angle: Jim Cramer analyzes the strategies employed by Starbucks' CEO to revitalize the brand.

Business & Industry

Briefing: Nike Takes 'Intentional' Hit To Clear 'Unhealthy Inventory' In Q3 As CEO Eyes Turnaround By Year-End

Strategic angle: Nike's strategic decision aims to address excess inventory and set the stage for recovery.

Business & Industry

Briefing: Congress gave money for global HIV work. The Trump administration isn't spending it

Strategic angle: U.S. work combatting HIV/AIDS has saved millions of lives globally. Under the Trump administration, funding has been slow in coming and unpredictable.

Business & Industry

Briefing: US Company Secures Major Mining Deal in Democratic Republic of Congo

Strategic angle: The $700 million acquisition of Chemaf highlights a strategic move in US mining diplomacy amid rising competition with China.